Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions
Системы замкнутого контура для доставки инсулина: прошлое, настоящее и перспективы развития
2022-06-06
SCID: 54.1/ewqpx7wn
Discuss with AI
artificial pancreasclosed-loop insulin deliverycontinuous glucose sensingglucagonhybrid closed-loop systems
Figures from the paper
Abstract (AI)
Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened to the holy grail of diabetes management. The first iterations of glucose-responsive insulin delivery were pioneered in the 1960s and 1970s, with the development of systems that used venous glucose measurements to dictate intravenous infusions of insulin and dextrose in order to maintain normoglycemia. Only recently have these bulky, bedside technologies progressed to miniaturized, wearable devices. These modern closed-loop systems use interstitial glucose sensing, subcutaneous insulin pumps, and increasingly sophisticated algorithms. As the number of commercially available hybrid closed-loop systems has grown, so too has the evidence supporting their efficacy. Future challenges in closed-loop technology include the development of fully closed-loop systems that do not require user input for meal announcements or carbohydrate counting. Another evolving avenue in research is the addition of glucagon to mitigate the risk of hypoglycemia and allow more aggressive insulin dosing.
Key Findings
1
A major future goal is fully closed-loop operation without user-entered meal announcements or carbohydrate-counting information.
2
Adding glucagon may reduce hypoglycemia risk and enable more aggressive insulin dosing in closed-loop systems.
3
Closed-loop technology has progressed from bulky bedside systems to wearable devices integrating interstitial glucose sensors, subcutaneous insulin pumps, and advanced control algorithms.
4
Early glucose-responsive insulin delivery systems, developed in the 1960s and 1970s, used venous glucose measurements to control intravenous insulin and dextrose infusions.
5
Growing evidence supports the efficacy of commercially available hybrid closed-loop insulin delivery systems.
Research Object
Closed-loop (artificial pancreas) systems for automated insulin delivery in diabetes management
Research Subject
The evolution, efficacy, and future development of glucose-responsive insulin delivery, including fully closed-loop operation and glucagon augmentation
Publication Details
Publication Date
2022-06-06
Journal
Publisher
ISSN
Cited by
151
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest